| NCT03361956 |
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03361956 |
Active, not recruiting |
Janssen Sciences Ireland UC |
2019-09-05 |
| NCT04082338 |
Chronic HBV Management for Asian American |
https://ClinicalTrials.gov/show/NCT04082338 |
Active, not recruiting |
Temple University |
2021-09-30 |
| NCT03320616 |
EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT03320616 |
Completed |
Enyo Pharma |
2017-10-12 |
| NCT03272009 |
Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects |
https://ClinicalTrials.gov/show/NCT03272009 |
Completed |
Enyo Pharma |
2018-07-30 |
| NCT03258710 |
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03258710 |
Completed |
GlaxoSmithKline |
2018-12-28 |
| NCT03241641 |
Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. |
https://ClinicalTrials.gov/show/NCT03241641 |
Active, not recruiting |
Asan Medical Center |
2020-03-31 |
| NCT03180619 |
Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) |
https://ClinicalTrials.gov/show/NCT03180619 |
Active, not recruiting |
Gilead Sciences |
2019-03-27 |
| NCT03180333 |
The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03180333 |
Completed |
Guangzhou Yipinhong Pharmaceutical CO.,LTD |
2012-08-31 |
| NCT03173599 |
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03173599 |
Completed |
Guangzhou Yipinhong Pharmaceutical CO.,LTD |
2011-04-30 |
| NCT03123653 |
To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy. |
https://ClinicalTrials.gov/show/NCT03123653 |
Active, not recruiting |
Institute of Liver and Biliary Sciences, India |
2019-09-17 |
| NCT03084250 |
The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC |
https://ClinicalTrials.gov/show/NCT03084250 |
Active, not recruiting |
Shanghai Nanhui Nanhua Hospital |
2023-04-01 |
| NCT03038113 |
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03038113 |
Completed |
Hoffmann-La Roche |
2019-10-18 |
| NCT03023787 |
Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03023787 |
Completed |
Shanghai HEP Pharmaceatical Co., Ltd. |
2016-12-31 |
| NCT03020745 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects |
https://ClinicalTrials.gov/show/NCT03020745 |
Completed |
GlaxoSmithKline |
2019-01-28 |
| NCT03013556 |
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03013556 |
Recruiting |
Ruijin Hospital |
2020-06-30 |
| NCT02992704 |
Peg-interferon for Inactive Chronic Hepatitis B Carriers |
https://ClinicalTrials.gov/show/NCT02992704 |
Active, not recruiting |
National University Health System, Singapore |
2019-08-31 |
| NCT02991638 |
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers |
https://ClinicalTrials.gov/show/NCT02991638 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT02981602 |
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection |
https://ClinicalTrials.gov/show/NCT02981602 |
Completed |
Ionis Pharmaceuticals, Inc. |
2019-12-18 |
| NCT02979613 |
Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed |
https://ClinicalTrials.gov/show/NCT02979613 |
Completed |
Gilead Sciences |
2018-09-10 |
| NCT02964910 |
A Phase â…£ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) |
https://ClinicalTrials.gov/show/NCT02964910 |
Completed |
Xiamen Innovax Biotech Co., Ltd |
2017-08-31 |
| NCT02956850 |
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531 |
https://ClinicalTrials.gov/show/NCT02956850 |
Recruiting |
Hoffmann-La Roche |
2021-02-10 |
| NCT02952924 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants |
https://ClinicalTrials.gov/show/NCT02952924 |
Recruiting |
Hoffmann-La Roche |
2021-06-30 |
| NCT02937779 |
Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission |
https://ClinicalTrials.gov/show/NCT02937779 |
Active, not recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-03-31 |
| NCT02908191 |
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02908191 |
Completed |
Assembly Biosciences |
2018-03-31 |
| NCT02881008 |
Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02881008 |
Completed |
Hepatera Ltd. |
2014-10-04 |
| NCT02838810 |
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT02838810 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2019-12-31 |
| NCT02792088 |
Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues |
https://ClinicalTrials.gov/show/NCT02792088 |
Recruiting |
IlDong Pharmaceutical Co Ltd |
2019-03-31 |
| NCT02791269 |
A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program |
https://ClinicalTrials.gov/show/NCT02791269 |
Completed |
Hoffmann-La Roche |
2008-07-31 |
| NCT02774837 |
Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02774837 |
Active, not recruiting |
National University Health System, Singapore |
2020-07-31 |
| NCT02745704 |
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT02745704 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2019-04-30 |
| NCT02743182 |
HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients |
https://ClinicalTrials.gov/show/NCT02743182 |
Completed |
Parc de Salut Mar |
2018-10-31 |
| NCT02738554 |
Off Treatment Durability in Chronic Hepatitis B With Good Immune Control |
https://ClinicalTrials.gov/show/NCT02738554 |
Completed |
The University of Hong Kong |
2020-01-31 |
| NCT02662712 |
A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II) |
https://ClinicalTrials.gov/show/NCT02662712 |
Completed |
Janssen Sciences Ireland UC |
2018-06-29 |
| NCT02646189 |
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC’) in HBV Infected Patients |
https://ClinicalTrials.gov/show/NCT02646189 |
Completed |
Replicor Inc. |
2013-08-31 |
| NCT02646163 |
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients |
https://ClinicalTrials.gov/show/NCT02646163 |
Completed |
Replicor Inc. |
2012-12-31 |
| NCT02631096 |
Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT02631096 |
Completed |
Arbutus Biopharma Corporation |
2018-05-18 |
| NCT02612506 |
Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02612506 |
Completed |
Shanghai HEP Pharmaceatical Co., Ltd. |
2016-08-31 |
| NCT02604823 |
A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT02604823 |
Completed |
Hoffmann-La Roche |
2005-11-30 |
| NCT02600117 |
Use of TDF in Patients With Inactive Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT02600117 |
Enrolling by invitation |
University Health Network, Toronto |
2022-05-31 |
| NCT02598063 |
A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02598063 |
Completed |
Hoffmann-La Roche |
2009-04-30 |
| NCT02589457 |
Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet |
https://ClinicalTrials.gov/show/NCT02589457 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-12-31 |
| NCT02570191 |
A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT02570191 |
Completed |
Hoffmann-La Roche |
2007-02-28 |
| NCT02569372 |
A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02569372 |
Completed |
Green Cross Corporation |
2017-10-12 |
| NCT02932150 |
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT02932150 |
Recruiting |
Gilead Sciences |
2023-02-28 |
| NCT02505009 |
Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy |
https://ClinicalTrials.gov/show/NCT02505009 |
Completed |
Chang Gung Memorial Hospital |
2018-12-21 |
| NCT02431312 |
Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects |
https://ClinicalTrials.gov/show/NCT02431312 |
Completed |
Inovio Pharmaceuticals |
2018-05-22 |
| NCT02428400 |
Safety and Tolerability of TG1050: A Dose-finding Study |
https://ClinicalTrials.gov/show/NCT02428400 |
Completed |
Transgene |
2018-11-30 |
| NCT02401737 |
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients |
https://ClinicalTrials.gov/show/NCT02401737 |
Completed |
Novira Therapeutics, Inc. |
2016-05-18 |
| NCT02391805 |
A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT02391805 |
Completed |
Hoffmann-La Roche |
2017-10-16 |
| NCT02366208 |
Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02366208 |
Completed |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
2013-06-30 |
| NCT02364336 |
Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment |
https://ClinicalTrials.gov/show/NCT02364336 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-05-21 |
| NCT02360592 |
Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02360592 |
Completed |
Tongji Hospital |
2016-12-31 |
| NCT02355951 |
Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection |
https://ClinicalTrials.gov/show/NCT02355951 |
Completed |
Transgene |
2016-02-29 |
| NCT02338674 |
TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction |
https://ClinicalTrials.gov/show/NCT02338674 |
Completed |
Fuzhou General Hospital |
2016-10-31 |
| NCT02332473 |
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02332473 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2016-02-29 |
| NCT02300688 |
Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT02300688 |
Completed |
IlDong Pharmaceutical Co Ltd |
2015-02-28 |
| NCT02287857 |
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02287857 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2019-10-31 |
| NCT02263079 |
A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase |
https://ClinicalTrials.gov/show/NCT02263079 |
Completed |
Hoffmann-La Roche |
2020-01-29 |
| NCT02249988 |
Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02249988 |
Completed |
Abivax S.A. |
2016-12-31 |
| NCT02224456 |
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02224456 |
Active, not recruiting |
GlaxoSmithKline |
2020-12-02 |
| NCT02202473 |
Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects |
https://ClinicalTrials.gov/show/NCT02202473 |
Completed |
Southeast University, China |
2014-02-28 |
| NCT02195518 |
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study |
https://ClinicalTrials.gov/show/NCT02195518 |
Completed |
GlaxoSmithKline |
2018-08-14 |
| NCT02174276 |
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment |
https://ClinicalTrials.gov/show/NCT02174276 |
Completed |
Gilead Sciences |
2016-02-17 |
| NCT02166047 |
Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects |
https://ClinicalTrials.gov/show/NCT02166047 |
Completed |
Gilead Sciences |
2016-05-31 |
| NCT02112799 |
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02112799 |
Completed |
Novira Therapeutics, Inc. |
2016-05-18 |
| NCT02097004 |
Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT02097004 |
Completed |
Seoul National University Hospital |
2018-01-31 |
| NCT02081469 |
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT02081469 |
Completed |
Chang Gung Memorial Hospital |
2019-08-05 |
| NCT02068365 |
An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT02068365 |
Completed |
Chinese University of Hong Kong |
2019-06-30 |
| NCT01277601 |
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01277601 |
Completed |
Gilead Sciences |
2014-08-31 |
| NCT03753074 |
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines |
https://ClinicalTrials.gov/show/NCT03753074 |
Recruiting |
Asan Medical Center |
2023-12-31 |
| NCT01651403 |
Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01651403 |
Active, not recruiting |
Gilead Sciences |
2017-08-07 |
| NCT03357822 |
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03357822 |
Recruiting |
Tongji Hospital |
2022-01-25 |
| NCT03356834 |
Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF |
https://ClinicalTrials.gov/show/NCT03356834 |
Recruiting |
Humanity and Health Research Centre |
2022-10-31 |
| NCT01997944 |
Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01997944 |
Completed |
Beijing Bio-Fortune Ltd. |
2014-09-30 |
| NCT01943799 |
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01943799 |
Completed |
Gilead Sciences |
2014-09-09 |
| NCT01937806 |
Phase 3 and Extensional Study of Besifovir |
https://ClinicalTrials.gov/show/NCT01937806 |
Active, not recruiting |
IlDong Pharmaceutical Co Ltd |
2016-02-29 |
| NCT01926288 |
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B |
https://ClinicalTrials.gov/show/NCT01926288 |
Completed |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2014-03-31 |
| NCT01913431 |
Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01913431 |
Completed |
Dong-A ST Co., Ltd. |
2015-11-06 |
| NCT01892241 |
Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA |
https://ClinicalTrials.gov/show/NCT01892241 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2012-11-30 |
| NCT01887275 |
A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01887275 |
Completed |
Nanfang Hospital of Southern Medical University |
2013-02-28 |
| NCT01817725 |
Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg |
https://ClinicalTrials.gov/show/NCT01817725 |
Completed |
Chang Gung Memorial Hospital |
2016-02-29 |
| NCT01813487 |
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E |
https://ClinicalTrials.gov/show/NCT01813487 |
Completed |
Genexine, Inc. |
2013-07-31 |
| NCT01787279 |
An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01787279 |
Completed |
Hoffmann-La Roche |
2009-05-31 |
| NCT01760122 |
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01760122 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2015-07-31 |
| NCT01745822 |
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand |
https://ClinicalTrials.gov/show/NCT01745822 |
Completed |
Institut de Recherche pour le Developpement |
2016-12-31 |
| NCT01743079 |
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B |
https://ClinicalTrials.gov/show/NCT01743079 |
Completed |
Beijing YouAn Hospital |
2013-07-31 |
| NCT01732367 |
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA |
https://ClinicalTrials.gov/show/NCT01732367 |
Completed |
Keimyung University Dongsan Medical Center |
2016-03-31 |
| NCT01728935 |
Tenofovir in Asian Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01728935 |
Completed |
The University of Hong Kong |
2012-11-30 |
| NCT01711567 |
Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir |
https://ClinicalTrials.gov/show/NCT01711567 |
Completed |
Korea University |
2015-12-31 |
| NCT01708889 |
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction |
https://ClinicalTrials.gov/show/NCT01708889 |
Completed |
Bristol-Myers Squibb |
2013-02-28 |
| NCT01706575 |
A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression |
https://ClinicalTrials.gov/show/NCT01706575 |
Completed |
Hoffmann-La Roche |
2013-09-30 |
| NCT04365933 |
A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir |
https://ClinicalTrials.gov/show/NCT04365933 |
Recruiting |
Enyo Pharma |
2021-01-31 |
| NCT01697501 |
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253 |
https://ClinicalTrials.gov/show/NCT01697501 |
Completed |
Hoffmann-La Roche |
2013-06-21 |
| NCT01671787 |
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01671787 |
Completed |
Gilead Sciences |
2013-04-30 |
| NCT01641536 |
Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01641536 |
Completed |
Genexine, Inc. |
2012-12-31 |
| NCT01639092 |
Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01639092 |
Completed |
Asan Medical Center |
2018-03-29 |
| NCT01639066 |
Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01639066 |
Completed |
Asan Medical Center |
2017-09-22 |
| NCT01595685 |
Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01595685 |
Completed |
Asan Medical Center |
2014-12-31 |
| NCT01590654 |
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01590654 |
Completed |
Gilead Sciences |
2013-11-30 |
| NCT01590641 |
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01590641 |
Completed |
Gilead Sciences |
2013-09-30 |
| NCT01546116 |
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) |
https://ClinicalTrials.gov/show/NCT01546116 |
Completed |
Korea University |
2012-02-29 |
| NCT01532843 |
Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB |
https://ClinicalTrials.gov/show/NCT01532843 |
Completed |
Foundation for Liver Research |
2015-08-31 |
| NCT01524679 |
Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen |
https://ClinicalTrials.gov/show/NCT01524679 |
Completed |
Johannes Gutenberg University Mainz |
2017-08-28 |
| NCT01522625 |
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation |
https://ClinicalTrials.gov/show/NCT01522625 |
Completed |
E-DA Hospital |
2018-11-30 |
| NCT01521975 |
A Two-year Study of Telbivudine in HBeAg Negative Hepatitis |
https://ClinicalTrials.gov/show/NCT01521975 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2014-02-28 |
| NCT01519960 |
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01519960 |
Active, not recruiting |
Hoffmann-La Roche |
2015-07-09 |
| NCT01519921 |
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. |
https://ClinicalTrials.gov/show/NCT01519921 |
Completed |
Hoffmann-La Roche |
2008-06-30 |
| NCT01480622 |
Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects |
https://ClinicalTrials.gov/show/NCT01480622 |
Completed |
GlaxoSmithKline |
2011-12-30 |
| NCT01480492 |
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection |
https://ClinicalTrials.gov/show/NCT01480492 |
Completed |
Changhai Hospital |
2011-10-31 |
| NCT01480284 |
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue |
https://ClinicalTrials.gov/show/NCT01480284 |
Completed |
GlaxoSmithKline |
2013-01-31 |
| NCT01475851 |
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs |
https://ClinicalTrials.gov/show/NCT01475851 |
Completed |
GlaxoSmithKline |
2013-06-30 |
| NCT01471535 |
HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated |
https://ClinicalTrials.gov/show/NCT01471535 |
Completed |
Beijing Ditan Hospital |
2012-12-31 |
| NCT01438424 |
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials |
https://ClinicalTrials.gov/show/NCT01438424 |
Completed |
Bristol-Myers Squibb |
2009-12-31 |
| NCT01412567 |
Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers |
https://ClinicalTrials.gov/show/NCT01412567 |
Completed |
Govind Ballabh Pant Hospital |
2010-06-30 |
| NCT01373684 |
PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01373684 |
Completed |
Foundation for Liver Research |
2019-10-28 |
| NCT01369212 |
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01369212 |
Active, not recruiting |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2020-07-31 |
| NCT01353742 |
Lamivudine and Adefovir Dipivoxil Fixed Dose Combination |
https://ClinicalTrials.gov/show/NCT01353742 |
Completed |
GlaxoSmithKline |
2011-04-12 |
| NCT01337791 |
Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels |
https://ClinicalTrials.gov/show/NCT01337791 |
Completed |
Southeast University, China |
2009-12-31 |
| NCT01326546 |
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01326546 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2014-01-31 |
| NCT01320943 |
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB |
https://ClinicalTrials.gov/show/NCT01320943 |
Completed |
Gilead Sciences |
2016-07-28 |
| NCT04225715 |
A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04225715 |
Recruiting |
Hoffmann-La Roche |
2021-12-18 |
| NCT04423393 |
Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04423393 |
Recruiting |
Vir Biotechnology, Inc. |
2022-08-31 |
| NCT04398134 |
A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04398134 |
Recruiting |
Assembly Biosciences |
2023-01-19 |
| NCT04289987 |
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine |
https://ClinicalTrials.gov/show/NCT04289987 |
Recruiting |
CHA Vaccine Institute Co., Ltd. |
2021-08-19 |
| NCT04271592 |
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04271592 |
Recruiting |
Assembly Biosciences |
2020-11-03 |
| NCT04248426 |
A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04248426 |
Recruiting |
Antios Therapeutics, Inc |
2021-08-31 |
| NCT04201808 |
Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides |
https://ClinicalTrials.gov/show/NCT04201808 |
Recruiting |
New Discovery LLC |
2021-09-30 |
| NCT04195074 |
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b |
https://ClinicalTrials.gov/show/NCT04195074 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2023-12-31 |
| NCT04189276 |
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT04189276 |
Recruiting |
Tasly Tianjin Biopharmaceutical Co., Ltd. |
2020-12-31 |
| NCT04182321 |
Adding Metformin to the Standard Treatment for Patients With HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04182321 |
Recruiting |
Beijing 302 Hospital |
2021-12-31 |
| NCT04180150 |
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04180150 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-09-30 |
| NCT04157699 |
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b |
https://ClinicalTrials.gov/show/NCT04157699 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
2020-12-31 |
| NCT04157257 |
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy |
https://ClinicalTrials.gov/show/NCT04157257 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
2020-12-31 |
| NCT04142762 |
A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04142762 |
Completed |
Assembly Biosciences |
2020-01-12 |
| NCT04133259 |
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT04133259 |
Recruiting |
Henlix, Inc |
2022-04-30 |
| NCT04129554 |
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04129554 |
Recruiting |
Janssen Sciences Ireland UC |
2022-01-31 |
| NCT04112147 |
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04112147 |
Recruiting |
Chung Shan Medical University |
2020-06-30 |
| NCT04102176 |
Halting Nucleoside Analogues in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04102176 |
Recruiting |
National University Health System, Singapore |
2021-03-31 |
| NCT04083716 |
A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04083716 |
Completed |
Assembly Biosciences |
2019-10-05 |
| NCT04070079 |
Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B: |
https://ClinicalTrials.gov/show/NCT04070079 |
Recruiting |
University Health Network, Toronto |
2022-08-30 |
| NCT04069858 |
Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04069858 |
Active, not recruiting |
Korea University |
2019-03-01 |
| NCT04035837 |
The Clinical Cure Project of Chronic Hepatitis B in China |
https://ClinicalTrials.gov/show/NCT04035837 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-12-30 |
| NCT04023721 |
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor |
https://ClinicalTrials.gov/show/NCT04023721 |
Active, not recruiting |
Spring Bank Pharmaceuticals, Inc. |
2020-06-30 |
| NCT03982186 |
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03982186 |
Recruiting |
Janssen Sciences Ireland UC |
2021-03-31 |
| NCT03933384 |
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03933384 |
Recruiting |
Taichung Veterans General Hospital |
2022-12-31 |
| NCT03905655 |
Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03905655 |
Recruiting |
Romark Laboratories L.C. |
2022-12-01 |
| NCT03847246 |
Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03847246 |
Completed |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2018-12-28 |
| NCT03801798 |
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03801798 |
Active, not recruiting |
Green Cross Corporation |
2021-12-31 |
| NCT03801538 |
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT03801538 |
Active, not recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2020-12-31 |
| NCT03792919 |
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) |
https://ClinicalTrials.gov/show/NCT03792919 |
Recruiting |
Humanity & Health Medical Group Limited |
2023-12-31 |
| NCT03780543 |
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03780543 |
Active, not recruiting |
Assembly Biosciences |
2021-06-30 |
| NCT03778567 |
Renoprotective Effects of Telbivudine in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03778567 |
Completed |
The University of Hong Kong |
2016-06-16 |
| NCT03772249 |
Study of Safety and Tolerability of DCR HBVS |
https://ClinicalTrials.gov/show/NCT03772249 |
Recruiting |
Dicerna Pharmaceuticals, Inc. |
2020-05-31 |
| NCT03762681 |
A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03762681 |
Active, not recruiting |
Hoffmann-La Roche |
2021-03-13 |
| NCT03759782 |
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity |
https://ClinicalTrials.gov/show/NCT03759782 |
Recruiting |
Ottawa Hospital Research Institute |
2020-01-03 |
| NCT03714152 |
A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03714152 |
Recruiting |
Assembly Biosciences |
2020-08-31 |
| NCT03681132 |
The Norwegian Nucleoside Analogue Stop Study |
https://ClinicalTrials.gov/show/NCT03681132 |
Active, not recruiting |
Oslo University Hospital |
2022-10-01 |
| NCT03672188 |
Study of VIR-2218 in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03672188 |
Active, not recruiting |
Vir Biotechnology, Inc. |
2021-03-31 |
| NCT03662568 |
A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03662568 |
Completed |
Sunshine Lake Pharma Co., Ltd. |
2018-07-31 |
| NCT03638076 |
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules |
https://ClinicalTrials.gov/show/NCT03638076 |
Recruiting |
Sunshine Lake Pharma Co., Ltd. |
2018-12-09 |
| NCT03615066 |
Safety, Tolerability, and Antiviral Activity of Selgantolimod in Viremic Adults With Chronic Hepatitis B Who Are Not Currently on Treatment |
https://ClinicalTrials.gov/show/NCT03615066 |
Active, not recruiting |
Gilead Sciences |
2019-12-12 |
| NCT03585322 |
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03585322 |
Recruiting |
Ascentage Pharma Group Inc. |
2021-10-30 |
| NCT03577171 |
A Study Evaluating ABI-H0731+ NUC vs NUC Alone for the Treatment of Viremic HBeAg-positive, CHB Patients |
https://ClinicalTrials.gov/show/NCT03577171 |
Completed |
Assembly Biosciences |
2019-06-21 |
| NCT03576066 |
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03576066 |
Completed |
Assembly Biosciences |
2019-07-05 |
| NCT03575208 |
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03575208 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-05-30 |
| NCT03546530 |
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03546530 |
Completed |
First Hospital of Jilin University |
2017-01-31 |
| NCT03491553 |
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03491553 |
Active, not recruiting |
Gilead Sciences |
2019-03-22 |
| NCT03485534 |
Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03485534 |
Recruiting |
Daewoong Pharmaceutical Co. LTD. |
2020-10-30 |
| NCT03471624 |
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF) |
https://ClinicalTrials.gov/show/NCT03471624 |
Active, not recruiting |
Stanford University |
2021-08-31 |
| NCT03469583 |
Drug Drug Interaction Study for EYP001 With Entecavir |
https://ClinicalTrials.gov/show/NCT03469583 |
Completed |
Enyo Pharma |
2018-06-20 |
| NCT03463369 |
A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed |
https://ClinicalTrials.gov/show/NCT03463369 |
Active, not recruiting |
Janssen Sciences Ireland UC |
2021-03-23 |
| NCT03439488 |
A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03439488 |
Completed |
Alios Biopharma Inc. |
2019-10-10 |
| NCT03434353 |
Study to Evaluate the Antiviral Activity of Inarigivir Soproxil (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT03434353 |
Active, not recruiting |
Gilead Sciences |
2020-01-20 |
| NCT03429439 |
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03429439 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-10-31 |
| NCT01264367 |
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+) |
https://ClinicalTrials.gov/show/NCT01264367 |
Completed |
Bukwang Pharmaceutical |
2013-08-31 |
| NCT01264354 |
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01264354 |
Completed |
Bukwang Pharmaceutical |
2012-08-31 |
| NCT01254994 |
The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure |
https://ClinicalTrials.gov/show/NCT01254994 |
Completed |
Sun Yat-sen University |
2009-07-31 |
| NCT01237496 |
Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253 |
https://ClinicalTrials.gov/show/NCT01237496 |
Completed |
Hoffmann-La Roche |
2009-09-30 |
| NCT01205165 |
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT01205165 |
Completed |
GlaxoSmithKline |
2006-04-28 |
| NCT01192854 |
An Study of Efficacy and Safety of Clevudine |
https://ClinicalTrials.gov/show/NCT01192854 |
Completed |
Eisai Inc. |
2011-05-31 |
| NCT01143662 |
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01143662 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2011-04-30 |
| NCT01098006 |
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays |
https://ClinicalTrials.gov/show/NCT01098006 |
Completed |
GlaxoSmithKline |
2012-02-20 |
| NCT01095835 |
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT01095835 |
Completed |
Hoffmann-La Roche |
2010-01-31 |
| NCT01088009 |
Efficacy Optimizing Research of Lamivudine Therapy |
https://ClinicalTrials.gov/show/NCT01088009 |
Completed |
Nanfang Hospital of Southern Medical University |
2013-02-28 |
| NCT01086085 |
A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive |
https://ClinicalTrials.gov/show/NCT01086085 |
Completed |
Hoffmann-La Roche |
2013-03-31 |
| NCT01079806 |
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01079806 |
Completed |
Bristol-Myers Squibb |
2013-03-31 |
| NCT01063036 |
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment |
https://ClinicalTrials.gov/show/NCT01063036 |
Completed |
Bristol-Myers Squibb |
2012-11-30 |
| NCT01037166 |
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy |
https://ClinicalTrials.gov/show/NCT01037166 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT01037062 |
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01037062 |
Completed |
Bristol-Myers Squibb |
2006-12-31 |
| NCT01026610 |
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01026610 |
Completed |
LG Life Sciences |
2010-11-30 |
| NCT01023230 |
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01023230 |
Completed |
Dynavax Technologies Corporation |
2011-05-31 |
| NCT01023217 |
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir |
https://ClinicalTrials.gov/show/NCT01023217 |
Completed |
Asan Medical Center |
2012-07-31 |
| NCT01022801 |
A Phase II Dose Response Study in Japan in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01022801 |
Completed |
Bristol-Myers Squibb |
2005-03-31 |
| NCT01020565 |
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01020565 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT01013272 |
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load |
https://ClinicalTrials.gov/show/NCT01013272 |
Completed |
The University of Hong Kong |
2010-07-31 |
| NCT00994773 |
Simvastatin for the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00994773 |
Completed |
Bader, Ted, M.D. |
2011-10-31 |
| NCT00988767 |
Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00988767 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2003-11-30 |
| NCT00975091 |
Continue Entecavir Rollover From China |
https://ClinicalTrials.gov/show/NCT00975091 |
Completed |
Bristol-Myers Squibb |
2007-08-31 |
| NCT00973219 |
Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load |
https://ClinicalTrials.gov/show/NCT00973219 |
Active, not recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2019-11-30 |
| NCT00962975 |
A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies |
https://ClinicalTrials.gov/show/NCT00962975 |
Completed |
Hoffmann-La Roche |
2013-05-31 |
| NCT00962871 |
A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both |
https://ClinicalTrials.gov/show/NCT00962871 |
Completed |
Hoffmann-La Roche |
2012-02-29 |
| NCT00962533 |
EFFicacy Optimization Research of Telbivudine Therapy |
https://ClinicalTrials.gov/show/NCT00962533 |
Completed |
Nanfang Hospital of Southern Medical University |
2012-04-30 |
| NCT00940485 |
A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00940485 |
Completed |
Hoffmann-La Roche |
2011-12-31 |
| NCT00936715 |
Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States |
https://ClinicalTrials.gov/show/NCT00936715 |
Completed |
Gilead Sciences |
2015-11-30 |
| NCT00927082 |
A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00927082 |
Completed |
Hoffmann-La Roche |
2014-11-30 |
| NCT00922207 |
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00922207 |
Completed |
Hoffmann-La Roche |
2014-09-29 |
| NCT00907894 |
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00907894 |
Completed |
Novartis |
2012-03-31 |
| NCT00895713 |
Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00895713 |
Completed |
Grifols Biologicals, LLC |
2005-06-30 |
| NCT00895596 |
Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00895596 |
Completed |
LG Life Sciences |
2006-08-31 |
| NCT00883844 |
PEG-IFN in HBV Patients With Incomplete Response to NA |
https://ClinicalTrials.gov/show/NCT00883844 |
Completed |
Foundation for Liver Research |
2012-06-30 |
| NCT00877760 |
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00877760 |
Completed |
Foundation for Liver Research |
2013-07-31 |
| NCT00877149 |
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00877149 |
Completed |
Novartis |
2011-04-30 |
| NCT00869778 |
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00869778 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2011-11-30 |
| NCT00857675 |
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00857675 |
Completed |
GlaxoSmithKline |
2008-03-31 |
| NCT04168333 |
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT04168333 |
Completed |
Tasly Tianjin Biopharmaceutical Co., Ltd. |
2019-10-14 |
| NCT04008004 |
A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) |
https://ClinicalTrials.gov/show/NCT04008004 |
Active, not recruiting |
Enanta Pharmaceuticals |
2020-12-31 |
| NCT03109730 |
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03109730 |
Completed |
Assembly Biosciences |
2018-03-31 |
| NCT02862106 |
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02862106 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2013-03-31 |
| NCT01928511 |
Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT01928511 |
Completed |
National University Health System, Singapore |
2018-12-31 |
| NCT01379508 |
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept |
https://ClinicalTrials.gov/show/NCT01379508 |
Completed |
Novartis |
2015-12-10 |
| NCT00838071 |
Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00838071 |
Completed |
Grifols Biologicals, LLC |
2004-07-31 |
| NCT00804622 |
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT00804622 |
Completed |
The University of Hong Kong |
2009-06-30 |
| NCT03625102 |
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03625102 |
Recruiting |
Golden Biotechnology Corporation |
2020-12-31 |
| NCT02862548 |
Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant |
https://ClinicalTrials.gov/show/NCT02862548 |
Active, not recruiting |
Gilead Sciences |
2018-02-08 |
| NCT02726789 |
Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02726789 |
Completed |
Replicor Inc. |
2016-09-30 |
| NCT02845401 |
The “HBV e-Antigen Negative Disease-Directly Offers” Study: Treatment Withdrawal in Patients With Early-Antigen Negative Chronic HBV |
https://ClinicalTrials.gov/show/NCT02845401 |
Active, not recruiting |
California Pacific Medical Center Research Institute |
2021-11-17 |
| NCT02579382 |
Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated |
https://ClinicalTrials.gov/show/NCT02579382 |
Completed |
Gilead Sciences |
2017-01-16 |
| NCT02565719 |
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT02565719 |
Completed |
Replicor Inc. |
2019-05-31 |
| NCT03468907 |
The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation |
https://ClinicalTrials.gov/show/NCT03468907 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2017-12-31 |
| NCT00781105 |
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00781105 |
Completed |
Novartis |
2010-09-16 |
| NCT00736190 |
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00736190 |
Completed |
Gilead Sciences |
2010-07-31 |
| NCT00734162 |
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00734162 |
Completed |
Gilead Sciences |
2011-03-31 |
| NCT00718887 |
Suboptimal Responders to Adefovir Switching to Entecavir |
https://ClinicalTrials.gov/show/NCT00718887 |
Completed |
Bristol-Myers Squibb |
2009-12-31 |
| NCT00686790 |
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) |
https://ClinicalTrials.gov/show/NCT00686790 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-31 |
| NCT00661076 |
ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00661076 |
Completed |
Hoffmann-La Roche |
2011-05-31 |
| NCT00651209 |
A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT00651209 |
Completed |
Novartis |
2011-12-31 |
| NCT00646503 |
Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00646503 |
Completed |
Novartis |
2009-09-30 |
| NCT00641082 |
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function |
https://ClinicalTrials.gov/show/NCT00641082 |
Completed |
Bukwang Pharmaceutical |
2012-03-31 |
| NCT00640588 |
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine |
https://ClinicalTrials.gov/show/NCT00640588 |
Completed |
Novartis |
2009-12-31 |
| NCT00637663 |
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA |
https://ClinicalTrials.gov/show/NCT00637663 |
Completed |
Pusan National University Hospital |
2010-11-30 |
| NCT00625339 |
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA |
https://ClinicalTrials.gov/show/NCT00625339 |
Completed |
Yonsei University |
2010-11-30 |
| NCT00614471 |
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B. |
https://ClinicalTrials.gov/show/NCT00614471 |
Completed |
Hoffmann-La Roche |
2009-10-31 |
| NCT00558818 |
Long-term Study With Clevudine |
https://ClinicalTrials.gov/show/NCT00558818 |
Completed |
Bukwang Pharmaceutical |
2011-09-30 |
| NCT00558493 |
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00558493 |
Completed |
Bukwang Pharmaceutical |
NA |
| NCT00537537 |
To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT00537537 |
Completed |
Novartis |
2011-06-30 |
| NCT00536627 |
Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis |
https://ClinicalTrials.gov/show/NCT00536627 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
2010-11-30 |
| NCT00536263 |
PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) |
https://ClinicalTrials.gov/show/NCT00536263 |
Completed |
Merck Sharp & Dohme Corp. |
2009-11-30 |
| NCT00531167 |
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00531167 |
Completed |
Korea University |
2011-04-30 |
| NCT00513968 |
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine |
https://ClinicalTrials.gov/show/NCT00513968 |
Completed |
Genexine, Inc. |
2010-04-30 |
| NCT00507689 |
Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant |
https://ClinicalTrials.gov/show/NCT00507689 |
Completed |
Gilead Sciences |
2011-05-31 |
| NCT00507507 |
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) |
https://ClinicalTrials.gov/show/NCT00507507 |
Completed |
Gilead Sciences |
2012-02-29 |
| NCT00487747 |
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. |
https://ClinicalTrials.gov/show/NCT00487747 |
Completed |
Hoffmann-La Roche |
2009-10-31 |
| NCT00467545 |
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00467545 |
Completed |
Novartis |
2009-09-30 |
| NCT00442572 |
SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). |
https://ClinicalTrials.gov/show/NCT00442572 |
Completed |
Hoffmann-La Roche |
2012-04-23 |
| NCT00441974 |
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients |
https://ClinicalTrials.gov/show/NCT00441974 |
Completed |
GlaxoSmithKline |
2008-09-30 |
| NCT00436163 |
A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00436163 |
Completed |
Hoffmann-La Roche |
2010-05-31 |
| NCT00435825 |
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB). |
https://ClinicalTrials.gov/show/NCT00435825 |
Completed |
Hoffmann-La Roche |
2010-12-31 |
| NCT00423891 |
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection |
https://ClinicalTrials.gov/show/NCT00423891 |
Completed |
Bristol-Myers Squibb |
2013-08-31 |
| NCT00412529 |
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00412529 |
Completed |
Novartis |
2008-02-29 |
| NCT00410202 |
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus |
https://ClinicalTrials.gov/show/NCT00410202 |
Completed |
Bristol-Myers Squibb |
2011-01-31 |
| NCT00410072 |
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00410072 |
Completed |
Bristol-Myers Squibb |
2010-10-31 |
| NCT00403585 |
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 |
https://ClinicalTrials.gov/show/NCT00403585 |
Completed |
GlaxoSmithKline |
2008-04-30 |
| NCT00397540 |
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT00397540 |
Completed |
Seoul National University Hospital |
2011-05-31 |
| NCT00395018 |
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT00395018 |
Completed |
Bristol-Myers Squibb |
2011-03-31 |
| NCT00393484 |
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00393484 |
Completed |
Bristol-Myers Squibb |
2009-01-31 |
| NCT00371761 |
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278) |
https://ClinicalTrials.gov/show/NCT00371761 |
Completed |
Merck Sharp & Dohme Corp. |
2009-02-28 |
| NCT00371150 |
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT00371150 |
Completed |
Bristol-Myers Squibb |
2011-03-31 |
| NCT00363155 |
KRN7000 in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00363155 |
Completed |
Foundation for Liver Research |
NA |
| NCT00354653 |
A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone |
https://ClinicalTrials.gov/show/NCT00354653 |
Completed |
ViiV Healthcare |
2007-01-23 |
| NCT00347009 |
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis |
https://ClinicalTrials.gov/show/NCT00347009 |
Completed |
GlaxoSmithKline |
2009-09-30 |
| NCT00338780 |
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) |
https://ClinicalTrials.gov/show/NCT00338780 |
Completed |
Chinese University of Hong Kong |
NA |
| NCT00324961 |
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00324961 |
Completed |
GlaxoSmithKline |
2009-01-31 |
| NCT00316719 |
Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00316719 |
Completed |
GlaxoSmithKline |
2008-01-31 |
| NCT00307489 |
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil |
https://ClinicalTrials.gov/show/NCT00307489 |
Completed |
Gilead Sciences |
2008-01-31 |
| NCT00307242 |
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00307242 |
Completed |
Thomas Jefferson University |
NA |
| NCT00298363 |
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. |
https://ClinicalTrials.gov/show/NCT00298363 |
Completed |
Gilead Sciences |
2011-04-30 |
| NCT00291616 |
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00291616 |
Completed |
Seoul National University Hospital |
2008-08-31 |
| NCT00277576 |
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00277576 |
Completed |
PowderMed |
NA |
| NCT00275938 |
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00275938 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00275652 |
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. |
https://ClinicalTrials.gov/show/NCT00275652 |
Completed |
Mayo Clinic |
2007-08-31 |
| NCT00230503 |
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B |
https://ClinicalTrials.gov/show/NCT00230503 |
Completed |
Bausch Health Americas, Inc. |
2006-12-31 |
| NCT00230477 |
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT |
https://ClinicalTrials.gov/show/NCT00230477 |
Completed |
University of Washington |
NA |
| NCT00226447 |
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00226447 |
Completed |
Chinese University of Hong Kong |
2006-07-31 |
| NCT00226382 |
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment |
https://ClinicalTrials.gov/show/NCT00226382 |
Completed |
Chinese University of Hong Kong |
2008-04-30 |
| NCT00142298 |
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies |
https://ClinicalTrials.gov/show/NCT00142298 |
Completed |
Novartis |
2009-11-30 |
| NCT00140725 |
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT00140725 |
Completed |
GlaxoSmithKline |
NA |
| NCT00132652 |
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00132652 |
Completed |
Novartis |
2006-12-31 |
| NCT00131742 |
Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00131742 |
Completed |
Novartis |
2007-01-31 |
| NCT00128544 |
Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00128544 |
Completed |
Novartis |
2007-05-31 |
| NCT00124241 |
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00124241 |
Completed |
Novartis |
2003-02-28 |
| NCT00120354 |
Long-Term Lamivudine Therapy for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00120354 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00117676 |
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00117676 |
Completed |
Gilead Sciences |
2007-04-30 |
| NCT00116805 |
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00116805 |
Completed |
Gilead Sciences |
2007-05-31 |
| NCT00115245 |
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00115245 |
Completed |
Novartis |
2006-08-31 |
| NCT00111943 |
Safety and Acceptability of a Vaginal Microbicide |
https://ClinicalTrials.gov/show/NCT00111943 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00096785 |
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00096785 |
Completed |
Bristol-Myers Squibb |
2006-01-31 |
| NCT00095121 |
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00095121 |
Completed |
Gilead Sciences |
2006-05-31 |
| NCT00076336 |
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis |
https://ClinicalTrials.gov/show/NCT00076336 |
Completed |
Novartis |
2009-12-31 |
| NCT00071201 |
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00071201 |
Completed |
Gilead Sciences |
2006-03-31 |
| NCT00057265 |
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00057265 |
Completed |
Novartis |
2006-04-30 |
| NCT00048945 |
Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00048945 |
Completed |
Hoffmann-La Roche |
2004-10-31 |
| NCT00036608 |
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine |
https://ClinicalTrials.gov/show/NCT00036608 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT00035789 |
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen |
https://ClinicalTrials.gov/show/NCT00035789 |
Completed |
Bristol-Myers Squibb |
2005-05-31 |
| NCT00035633 |
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen |
https://ClinicalTrials.gov/show/NCT00035633 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT00034359 |
Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT00034359 |
Completed |
Alexion Pharmaceuticals |
2003-01-31 |
| NCT00023309 |
Lamivudine and Adefovir to Treat Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00023309 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-04-30 |
| NCT00625560 |
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA |
https://ClinicalTrials.gov/show/NCT00625560 |
Completed |
Yonsei University |
2009-11-30 |
| NCT00023153 |
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection |
https://ClinicalTrials.gov/show/NCT00023153 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001457 |
Lamivudine for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00001457 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |